Keeley Teton Advisors LLC Decreases Stake in Cigna Corporation (CI)

Keeley Teton Advisors LLC decreased its position in Cigna Corporation (NYSE:CI) by 3.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,572 shares of the health services provider’s stock after selling 531 shares during the quarter. Keeley Teton Advisors LLC’s holdings in Cigna were worth $2,724,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of CI. JPMorgan Chase & Co. grew its position in shares of Cigna by 40.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock worth $684,413,000 after acquiring an additional 1,184,632 shares in the last quarter. Investec Asset Management LTD boosted its position in Cigna by 35.4% during the 3rd quarter. Investec Asset Management LTD now owns 1,849,598 shares of the health services provider’s stock valued at $345,764,000 after purchasing an additional 483,904 shares during the period. FMR LLC boosted its position in Cigna by 6.7% during the 2nd quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock valued at $1,156,604,000 after purchasing an additional 432,978 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in Cigna by 4,082.8% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 438,231 shares of the health services provider’s stock valued at $73,355,000 after purchasing an additional 427,754 shares during the period. Finally, Vanguard Group Inc. boosted its position in Cigna by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock valued at $2,867,514,000 after purchasing an additional 424,469 shares during the period. Institutional investors own 87.85% of the company’s stock.

Shares of Cigna Corporation (CI) opened at $206.00 on Friday. Cigna Corporation has a 12 month low of $131.03 and a 12 month high of $212.46. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $50,790.00, a price-to-earnings ratio of 19.67, a PEG ratio of 1.56 and a beta of 0.50.

Cigna (NYSE:CI) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, topping the Zacks’ consensus estimate of $2.36 by $0.47. Cigna had a return on equity of 18.85% and a net margin of 5.74%. The company had revenue of $10.38 billion for the quarter, compared to the consensus estimate of $10.17 billion. During the same quarter in the previous year, the business earned $1.94 EPS. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. research analysts forecast that Cigna Corporation will post 10.34 earnings per share for the current fiscal year.

A number of research analysts recently issued reports on the company. Citigroup boosted their price objective on Cigna from $198.00 to $231.00 and gave the company a “buy” rating in a research report on Friday, November 3rd. Morgan Stanley boosted their price objective on Cigna from $195.00 to $223.00 and gave the company an “overweight” rating in a research report on Friday, November 3rd. Jefferies Group boosted their price objective on Cigna from $221.00 to $231.00 and gave the company a “buy” rating in a research report on Friday, November 3rd. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $220.00 target price (up previously from $185.00) on shares of Cigna in a research note on Friday, November 3rd. Finally, Zacks Investment Research downgraded Cigna from a “buy” rating to a “hold” rating in a research note on Friday, November 10th. Three analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $201.50.

In related news, insider Christopher J. Hocevar sold 8,387 shares of Cigna stock in a transaction on Monday, November 27th. The stock was sold at an average price of $200.32, for a total value of $1,680,083.84. Following the transaction, the insider now directly owns 12,363 shares in the company, valued at approximately $2,476,556.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Alan Muney sold 15,345 shares of Cigna stock in a transaction on Monday, November 27th. The stock was sold at an average price of $200.80, for a total value of $3,081,276.00. Following the completion of the transaction, the executive vice president now owns 28,457 shares in the company, valued at $5,714,165.60. The disclosure for this sale can be found here. Insiders sold a total of 36,203 shares of company stock worth $7,211,251 in the last three months. Company insiders own 1.30% of the company’s stock.

WARNING: This piece was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://sportsperspectives.com/2017/12/08/keeley-teton-advisors-llc-decreases-stake-in-cigna-corporation-ci.html.

Cigna Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply